Triple Threat: Myocardial Ischemia Following Intracavernous Injection

Abstract

Erectile dysfunction is a form of male sexual dysfunction affecting 30 million men in the United States. 1 Due to efficacy, ease of use, and favorable side effect profile, phosphodiesterase inhibitors are the first line therapy for erectile dysfunction. 1,2 Other treatment options include intracavernous injection, testosterone replacement, vacuum devices, and penile prosthesis. 2 Despite the efficacy of alternative therapies, 2 associated side effects may be potentially lifethreatening as suggested by the following case.